InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Features of Swiss-type claims

Managing Intellectual Property


Methods for the diagnosis or treatment of diseases can receive protection in China if presented in a Swiss-type claim. Liantao Li and Tina H. Tai from China Patent Agent (HK) explain this process

Methods for the diagnosis or treatment of diseases are subject matters excluded from patentability in all nations except a few countries such as the US. In most nations and regions such as Europe, Japan and China, however, protection has been made available for new medical or pharmaceutical uses of known compounds/compositions if presented in a Swiss-type claim. This has also been expanded to protect new dosage regimens of known medicaments in Europe.

In response to such an expansion, the Chinese Patent Office (CPO) takes a very conservative position. For example, in its office actions, the CPO typically comments as the following: "A daily dose of 10mg and oral dosing are both an administration feature of a medicament. As a general rule, such a feature of administration per se does not serve as a definition of, or limitation on, a technical solution of any process/use for preparing the medicament".


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Our weekly round-up: Teleworking, Apple, Aereo, Canadian trade marks, patent reform latest http://t.co/RznN1hcQkY http://t.co/rwn9PPTQhh

Nov 22 2014 10:08 ·  reply ·  retweet ·  favourite
ManagingIP profile

Further judgment in ASSIA v BT ADSL patent litigation today http://t.co/Mbcz1buWMa SC appeal denied. Sounds like BT developing workaround

Nov 21 2014 04:06 ·  reply ·  retweet ·  favourite
ManagingIP profile

Merck trademark coexistence agreement governed by German (not US) law - English judge http://t.co/74h5PPvf4s

Nov 21 2014 04:03 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


AIPLA Daily Report 2014

Read this year's AIPLA Daily Report - published daily by Managing IP direct from the AIPLA Annual Meeting in Washington DC


null null null

November 2014

Asian governments focus on IP and competition issues

The interplay between patents essential to telecommunication standards and anti-monopoly concerns has turned the spotlight on how competition law will apply to IP protection. As governments in Asia begin to tackle these issues, it is becoming clear that there will be an impact on all major forms of IP and across a wide range of industries. Peter Leung reports



Most read articles

Supplements